This is a summary of published positions, not advice. UK health bodies describe vaping as far less harmful than smoking while stressing it is not risk-free. US agencies are more cautious, and no e-cigarette is FDA-approved as a quit aid. Clinical researchers report measurable effects, but no one has long-term data yet.
What Products Does the Research Cover, and How Are They Regulated?
Most research compares two product categories. Combustible cigarettes burn tobacco and deliver nicotine in smoke. E-cigarettes heat a liquid, usually containing nicotine, propylene glycol, vegetable glycerin, and flavorings, into an aerosol. Within e-cigarettes, studies cover several formats: disposable devices, closed pod systems and refillable tanks, along with two main liquid types, freebase nicotine and nicotine salts e-liquids for smoother, higher-nicotine options, a formulation that allows higher nicotine concentrations with less throat irritation.
Regulation differs sharply between countries. In the US, the FDA must authorize every e-cigarette product before it can be legally sold, through the premarket tobacco product application process. The agency has authorized a few dozen products, including several Juul products in July 2025, and stresses that authorization does not mean a product is safe or “FDA approved.” In the UK, products are notified to the Medicines and Healthcare products Regulatory Agency, nicotine liquids are capped at 20 mg/ml, and single-use disposable vapes have been banned since June 2025 on environmental grounds. Sales to minors are prohibited in both countries.
Those regulatory differences shape how each country’s health bodies describe the evidence, which is why their public positions differ.
Where Does the UK Position Sit?
UK health bodies use comparatively permissive language about relative risk. NHS Better Health states that nicotine vaping is not risk-free but is less harmful than smoking, and cites a 2022 evidence review commissioned by the government, which concluded that in the short and medium term vaping poses a small fraction of the risks of smoking. Cancer Research UK takes a similar view, stating that e-cigarettes are far less harmful than tobacco and that there is no good evidence vaping causes cancer.
UK public health statements also attach firm conditions. Local NHS and public health position statements repeat that vaping is not risk-free, that people who do not smoke should not vape, and that the relative-risk comparison applies only to people who would otherwise smoke.
Where Does the US Position Sit?
US agencies are more cautious. The CDC states that there is no safe tobacco product and that e-cigarettes are not safe for young people, pregnant adults, or adults who do not already use tobacco. It also notes that the long-term health effects of e-cigarettes are still unknown.
The FDA’s position adds a regulatory point. No e-cigarette has been approved in the US as a smoking cessation therapy, and the National Institute on Drug Abuse noted in September 2025 that the FDA had not received any application seeking such approval. Marketing an e-cigarette as a cessation device without FDA approval is not permitted.
The US experience also includes the 2019 to 2020 outbreak of e-cigarette or vaping use-associated lung injury, known as EVALI. By February 2020, the CDC had recorded 2,807 hospitalized cases and 68 deaths, most of them linked to illicit THC-containing products and the additive vitamin E acetate.
Where Does Clinical Literature Sit?
Clinical researchers mostly hold a middle position. Johns Hopkins Medicine summarizes its view as vaping being less harmful than smoking but still not safe, noting that e-cigarettes expose users to fewer toxic chemicals than cigarettes while still delivering nicotine, which can raise blood pressure and heart rate. The American Heart Association has warned about the cardiovascular effects of e-cigarette use and does not recommend e-cigarettes as a tool for quitting smoking.
Peer-reviewed studies indexed in PubMed Central have measured short-term changes in heart and lung function among people who vape, including effects on blood vessel function and airway irritation. These studies measure physiological changes over weeks or months rather than disease outcomes over decades.
The table below sets the main positions side by side.
| Body |
Country |
Position as stated |
| NHS Better Health |
UK |
Not risk-free, less harmful than smoking |
| Cancer Research UK |
UK |
Far less harmful than tobacco, no good evidence it causes cancer |
| CDC |
US |
No safe tobacco product, long-term effects unknown |
| FDA |
US |
Authorized products are not “safe” or “FDA approved,” none approved for cessation |
| Johns Hopkins Medicine |
US |
Less harmful than smoking, still not safe |
| American Heart Association |
US |
Cardiovascular concerns, not recommended as a quit tool |
The bodies listed agree on some points and disagree on others, and none of them speaks for the rest.
What Does Nobody Claim?
No health body claims to have long-term outcome data. Modern e-cigarettes have been widely used only since the late 2000s and early 2010s, and diseases such as lung cancer, chronic obstructive pulmonary disease and heart disease can take decades to develop. Multi-decade studies of the kind that established the harms of smoking do not yet exist for vaping, and both the UK and US positions acknowledge that gap.
Nobody describes vaping as safe, and none recommends it for people who do not already smoke.
Why Do the Positions Diverge?
Several factors explain why bodies looking at overlapping evidence reach different public positions. Regulatory frameworks differ: the UK treats e-cigarettes primarily as consumer products with medicinal oversight available, while the US regulates them as tobacco products through the FDA. Baseline smoking rates and youth vaping rates differ between the two countries, which shifts which risks each authority emphasizes. Precautionary thresholds also differ, with some bodies weighing the comparison against smoking and others weighing the comparison against not using nicotine at all.
Frequently Asked Questions
What are the main risks of vaping?
US and clinical sources list nicotine dependence, effects on heart rate and blood pressure, airway irritation, and unknown long-term effects.
Which is worse, cigarettes or vaping?
UK health bodies describe vaping as far less harmful than smoking. US agencies emphasize that no tobacco product is safe.
Do health bodies agree on vaping?
No. UK and US bodies differ in emphasis, mainly because of different regulatory frameworks and precautionary thresholds.
Is there long-term research on vaping?
Not yet. The products are too new for multi-decade outcome studies, a gap acknowledged by both UK and US bodies.
